Vor Biopharma Inc.

VORNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

Net Income

-$696.0M

▼ 495.3% YoY

EPS

$-70.50

▼ 107.2% YoY

Cash

$396.5M

▲ 383.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.